Related Experiment Video
Updated: Sep 25, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G alphaB-crystallin
Aura T Chávez Zobel1, Anne Loranger, Normand Marceau
1Centre de recherche en cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, 9 rue McMahon, Québec, Canada G1R 2J6.
Abstract:
A familial form of desmin-related myopathy (DRM) is associated with a missense mutation (R120G) in alphaB-crystallin (alphaB) and is characterized by intracellular desmin aggregation. Because alphaB is a molecular chaperone that participates in the assembly of desmin filaments, it has been suggested that the desmin aggregation might be due to the loss of alphaB function. We report here that alphaBR120G has indeed impaired in vivo function and structure as reflected by a highly reduced capacity to protect cells against heat shock and by an abnormal supramolecular organization even in cells not expressing desmin. In many cells, alphaBR120G accumulated in inclusion bodies that had characteristics of aggresomes concentrating around the centrosome following a microtubule-facilitated process. Three distinct chaperone mechanisms could reduce or even prevent the formation of the alphaBR120G aggresomes. Wild-type alphaB and Hsp27 prevented aggresome formation by co-oligomerizing with alphaBR120G. Hsp70 with its co-chaperone Hdj-1 or Chip-1 but not a mutant of Chip-1 lacking ubiquitin ligase activity, reduced the frequency of aggresome formation likely by targeting alphaBR120G for degradation. Finally, HspB8 interacted only transiently with alphaB but nonetheless rescued the alphaBR120G oligomeric organization, suggesting that it acted as a true chaperone assisting in the folding of the mutant protein. Hence, the formation of inclusion bodies in alphaBR120G-mediated DRM is probably due to the misfolding of alphaBR120G per se and can be delayed or prevented by expression of the wild type alphaB allele or other molecular chaperones, thereby explaining the adult onset of the disease.
Insights
A mutation in alphaB-crystallin (alphaB) causes desmin-related myopathy (DRM) by impairing its chaperone function, leading to protein aggregation. Other chaperones can prevent or reduce this aggregation, suggesting therapeutic potential.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Familial desmin-related myopathy (DRM) is linked to a specific mutation (R120G) in alphaB-crystallin (alphaB), a molecular chaperone involved in desmin filament assembly.
- The aggregation of desmin in DRM suggests a potential loss of alphaB function as the underlying cause.
Purpose of the Study:
- To investigate the in vivo function and structural integrity of the mutant alphaBR120G.
- To explore the mechanisms by which other molecular chaperones interact with and potentially mitigate the effects of alphaBR120G.
Main Methods:
- Assessed the heat shock protection capacity of alphaBR120G.
- Examined the supramolecular organization and aggresome formation of alphaBR120G in cells.
- Investigated the effects of wild-type alphaB, Hsp27, Hsp70/Hdj-1, Chip-1, and HspB8 on alphaBR120G aggresome formation.
Main Results:
- AlphaBR120G demonstrated significantly impaired heat shock protection and abnormal organization, forming aggresomes.
- Wild-type alphaB and Hsp27 prevented aggresome formation via co-oligomerization.
- Hsp70/Hdj-1 and Chip-1 reduced aggresome formation, likely through degradation, while HspB8 rescued oligomeric organization, suggesting a folding-assist role.
Conclusions:
- The R120G mutation in alphaB-crystallin leads to its misfolding and subsequent aggresome formation, causing DRM.
- The adult onset of DRM may be explained by the ability of wild-type alphaB or other chaperones to delay or prevent aggregation.
- Targeting chaperone interactions presents a potential therapeutic strategy for alphaB-crystallin-related myopathies.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Bacterial Protein Maturation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

